FDA Inspection 1249475 — Central Maine Medical Center/BB
The FDA completed an inspection of Central Maine Medical Center/BB on Sep 5, 2024 in Lewiston, ME. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 5, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lewiston, ME (United States)